Intravacc Email Format
Biotechnology ResearchUtrecht, Netherlands11-50 Employees
Intravacc is a biotechnology firm that concentrates on vaccines, helping move concepts from discovery toward late-stage clinical development while reducing associated risks and costs. It functions as an independent contract development and manufacturing organization, serving as a bridge between discovery and the start of Phase I/II clinical trials in humans. The company is based in Bilthoven, in the Utrecht region of the Netherlands, and operates as part of Utrecht Science Park Bilthoven. Its client base includes researchers and vaccine developers seeking to advance preventive and therapeutic vaccines through translational work with an established CDMO. In 2026, Intravacc announced a strategic partnership with Primordial Genetics Inc. to support the development and supply of conjugate vaccines.